Startups
JDRF International
Edit

JDRF International

Trusted
https://www.jdrf.org/
Last activity: 12.11.2025
Active
Categories: CenterDeliveryDevelopmentDrugIndustryInformationMovingNonprofitResearch
JDRF is the only global organization with a strategic research plan to end type 1 diabetes (T1D). Our plan ensures that there will be an ongoing stream of life-changing therapies moving from development through to commercialization that lessen the impact of T1D. We want to keep people with T1D healthy and safe today until we reach our ultimate goal of a cure and universal prevention of T1D.

JDRF collaborates with a wide spectrum of partners at every stage of the drug delivery pipeline and is the only organization with the scientific resources, regulatory influence, and a strategic plan to deliver a world without T1D. JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia and clinicians, because curing T1D is a global, coordinated effort with JDRF at the center.

For more information, please visit www.jdrf.org.
Likes
230.37K
Followers
26.71K
Website visits
260.3K /mo.
Mentions
158

Overview

Location
United States, New York
Employees
501-1000
Phone
800-533
Total raised
$11.65M
Founded date
1970

Funding Rounds 4

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see
Dec 15, 2020Funding round$8.5M
Oct 16, 2020Funding round$800K
Oct 9, 2013Funding round$1.75M

Mentions in press and media 158

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Sep 24, 2025Local American Ninja Warrior with diabetes dreams Olympics, advocates for T1DKatie Bone, a 19-year-old Northern Colorado resident, wants to keep her focus on Olympic dreams. Of course, that can be difficult when her blood sugar levels keep seizing her attention. Bone was diagnosed with Type 1 diabetes at age 11, and...
Nov 13, 2024Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery TechnologiesBRADENTON, Fla. and HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and drug deliv...
Aug 21, 2024New Frontiers in Medical Technology: RefluxStop™ and Type 1 Diabetes AwarenessIn the ever-evolving landscape of medical technology, two recent developments stand out: the promising results of the RefluxStop™ device and the launch of the "Detect So You Can Decide" campaign by Breakthrough T1D. Both initiativ...
Aug 15, 2024Breakthrough T1D Launches "Detect So You Can Decide" National Campaign to Increase Type 1 Diabetes Awareness and Early DetectionEarly Detection of Type 1 Diabetes Can Help Reduce the Risk of Life-Threatening Complications at Diagnosis and Allow Time to Access Therapy that Can Delay the Onset of the Disease NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Today, Breakthrough ...
Jul 30, 2024Diamyd Medical Announces Positive Interim Analysis Results for Phase 3 Trial in Type 1 DiabetesDiamyd Medical Announces Positive Interim Analysis Results for Phase 3 Trial in Type 1 Diabetes Tue, Jul 30, 2024 20:50 CET Report this content Diamyd Medical today announced a successful interim analysis (non-futility test) for its ongoing...
Jun 26, 2024Epilepsy Foundation Welcomes New Chief Development OfficerKatherine Griswold Brings More than 15 Years of Nonprofit Development Experience BOWIE, Md., June 26, 2024 /PRNewswire/ -- The Epilepsy Foundation today announced the appointment of Katherine Griswold as the new chief development officer. I...
Jun 24, 2024Landmark International Consensus Guidance Provides a Framework for Clinicians to Monitor Those in Early-Stage Type 1 DiabetesCo-published in Diabetes Care and Diabetologia, the first international type 1 diabetes monitoring consensus delineates clear guidance for healthcare professionals to track and treat people who test positive for diabetes autoantibodies Guid...
May 22, 2024JDRF Celebrates Asian American and Pacific Islander Month with the Announcement of Princess Padmaja Kumari Parmar as the Organization's Newest Global AmbassadorDiagnosed with type 1 diabetes at age five, Princess Padmaja joins forces with JDRF to raise awareness and combat stigma Type 1 diabetes is an autoimmune disease that causes the pancreas to make very little insulin or none at all NEW YORK, ...
May 16, 2024Diamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollmentDiamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollment Thu, May 16, 2024 10:15 CET Report this content Interim Analysis outcome scheduled for beginning of August The Interim Analysis will be con...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about JDRF International

When was JDRF International founded?

JDRF International was founded in 1970.

How much funding has JDRF International raised?

JDRF International has raised $11.65M in total across 4 funding rounds.

What funding rounds has JDRF International raised?

Parsers VC lists 4 funding rounds of JDRF International, among them a funding round of $8.5M on Dec 15, 2020, a funding round of $800K on Oct 16, 2020 and a funding round of $1.75M on Oct 9, 2013.

What has the press written about JDRF International?

Parsers VC has collected 158 articles mentioning JDRF International, among them “Local American Ninja Warrior with diabetes dreams Olympics, advocates for T1D” (Sep 24, 2025) and “Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies” (Nov 13, 2024).

Is JDRF International still active?

Yes, JDRF International is active; its latest activity on Parsers VC dates from Nov 12, 2025.